Evidence map›Paper›PMID 40896388›Full record

ArticleIDCases2025

Descending necrotizing mediastinitis caused by Group A

Ken-Ichiro Kobayashi, Kenji Kubo, Nobuhiro Komiya

Abstract readCase Reports
In one paragraph

Article in IDCases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ken-Ichiro KobayashiDepartment of Infectious Diseases, Japanese Red Cross Wakayama Medical Center, Japan.
Kenji KuboDepartment of Infectious Diseases, Japanese Red Cross Wakayama Medical Center, Japan.
Nobuhiro KomiyaDepartment of Infectious Diseases, Japanese Red Cross Wakayama Medical Center, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Descending necrotizing mediastinitis (DNM), a severe complication arising from deep neck infection, developed in an obese 45-year-old Japanese male with diabetes. His condition was caused by a Group A Streptococcus (GAS) infection that arose following an earlier influenza A infection during a seasonal influenza outbreak. The patient had a good clinical course with surgical drainage and debridement with antibiotic treatment. Pre-existing medical conditions and co-infections such as influenza increase susceptibility to GAS infection, and invasive GAS infection leads to increased mortality. The patient initially presented with fever, sore throat, and cough following influenza A infection, symptoms that were difficult to distinguish from those of deep neck infection caused by GAS. As the GAS was detected in blood cultures, the initial diagnosis was primary bacteremia following influenza A. Subsequently, however, the appearance of erythema on the anterior neck and around the thyroid cartilage suggested a descending progression of the infection from the deep neck space. Contrast-enhanced CT led to a diagnosis of DNM. The reported cases of DNM associated with viral infections have so far been limited to those following varicella or Epstein-Barr virus (EBV) infection. To our knowledge, this is the first reported case of DNM caused by GAS associated with influenza A infection. DNM caused by GAS is a rare infection that requires prompt surgical intervention followed by thorough systemic management. Clinicians should carefully monitor patients with underlying medical conditions who manifest recurrent or new symptoms such as fever, sore throat, and dyspnea after influenza infection.

Indexed as

Descending necrotizing mediastinitis (DNM)Group A Streptococcus (GAS)Influenza A

Identifiers

PMID40896388
PMCPMC12398227

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.